Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care

The field of acquired CNS neuroimmune demyelination in children is transforming. Although biological therapies have proven highly effective in adult-onset disease (e.g. multiple sclerosis), rarity in the paediatric age group necessitates new approaches to trial design.

Source:

The Lancet Neurology